false 0001563665 0001563665 2024-06-20 2024-06-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 20, 2024

 

HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-35853   45-5210462

(State or other jurisdiction

of incorporation)

   (Commission
File Number) 		  (IRS Employer
Identification No.)

 

84 October Hill Road, Suite 11, Holliston, MA   01746
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (774) 233-7300

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On June 20, 2024, Harvard Apparatus Regenerative Technology, Inc., or the Company, held its Annual Meeting of Stockholders, or the Annual Meeting. At the Annual Meeting, the Company’s stockholders voted on the following proposals: (i) the election of three Director Nominees as Class II Directors, each nominated by the Board of Directors of the Company for a three-year term, such term to continue until the annual meeting of stockholders in 2027 and until such Director’s successor is duly elected and qualified or until their earlier resignation or removal, (ii) the ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, and (iii) the non-binding approval of the compensation of the Company’s named executive officers. The voting results for the matters submitted to a stockholder vote at the Annual Meeting are reported below.

 

Proposal 1 - Election of Directors

 

On such election of directors proposal, each of David Green, Ting Li, and Ronald Packard were elected as Class II Directors, each for a three-year term, such term to continue until the annual meeting of stockholders in 2027 and until such Director’s successor is duly elected and qualified or until their earlier resignation or removal. Due to the plurality election, votes could only be cast in favor of or withheld from the nominee and thus votes against were not applicable. The results of the election were as follows:

 

Name  Votes For  Votes Withheld 

Broker Non-Votes

David Green  826,014  7,222,665  1,695,472
Ting Li  7,219,675  829,004  1,695,472
Ronald Packard  6,543,481  1,505,198  1,695,472

 

Proposal 2 – Ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024

 

The ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm was approved as follows:

 

Votes For  Votes Against  Votes Abstained  Broker Non-Votes
 9,738,743  2,678  2,730  0

 

Proposal 3 – Approval, by Non-Binding Advisory Vote, of the Compensation of the Company’s Named Executive Officers

 

The compensation of the Company’s named executive officers was approved, by a non-binding advisory vote, as follows:

 

Votes For  Votes Against  Votes Abstained  Broker Non-Votes
 8,033,183  14,649  847  0

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    HARVARD APPARATUS
REGENERATIVE TECHNOLOGY, INC.
    (Registrant)
     
June 24, 2024   /s/ Junli He
(Date)   Junli He
    Chief Executive Officer

 

 

v3.24.1.1.u2
Cover
Jun. 20, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 20, 2024
Entity File Number 001-35853
Entity Registrant Name HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC.
Entity Central Index Key 0001563665
Entity Tax Identification Number 45-5210462
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 84 October Hill Road
Entity Address, Address Line Two Suite 11
Entity Address, City or Town Holliston
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01746
City Area Code (774)
Local Phone Number 233-7300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Biostage (QB) (USOTC:BSTG)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Biostage (QB) Charts.
Biostage (QB) (USOTC:BSTG)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Biostage (QB) Charts.